Leading factors for progression of osteoarthritis of the knee. Effects of symptomatic slow release preparations on the course of the disease (5-year prospective study)


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Treatment of osteoarthritis (OA) is targeted both at the symptoms of the disease (reducing pain, inflammation, improving the functional state), and at slowing of the progression and improving the quality of life of patients. Symptomatic effects are achieved by a combination of non-pharmacological and pharmacological treatments provided by numerous recommendations. Currently, there is sufficient evidence that symptomatic slow release preparations have anti-inflammatory, analgesic and structure-modifying effects.

Full Text

Restricted Access

About the authors

N. G Kashevarova

FSBIS “Scientific Research Institute of Rheumatology n.a. V.A. Nasonova"

L. I Alekseeva

FSBIS “Scientific Research Institute of Rheumatology n.a. V.A. Nasonova"

Email: dr.alekseeva@gmail.com
MD, Head of the Division of Metabolic Diseases of Bones and Joints with the Center for the Prevention of Osteoporosis of RMH

E. A Taskina

FSBIS “Scientific Research Institute of Rheumatology n.a. V.A. Nasonova"

A. V Smirnov

FSBIS “Scientific Research Institute of Rheumatology n.a. V.A. Nasonova"

References

  1. Балабанова Р.М., Эрдес Ш.Ф. Динамика распространенности ревматических заболеваний, входящих в XIII класс МКБ-10, в популяции взрослого населения Российской Федерации за 2000-2010 гг. Научнопрактическая ревматология. 2012;3:10-2.
  2. Алексеева Л.И. Новые подходы к ведению больных остеоартрозом в реальной клинической практике. Практическая медицина. 2015;3-2(88):77-83.
  3. Алексеева Л.И. Симптоматические препараты замедленного действия при лечении ОА. Consilium medicus. 2009;11(9):100-4.
  4. Алексеева Л.И., Зайцева Е.М. Перспективные направления терапии остеоартроза. Научнопрактическая ревматология. 2014;3:247-49.
  5. Altman R. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Arthritis and Rheumatism. 1986; 29(8):1039-49.
  6. Kellgren J.H. Radiological assessment of osteoarthrosis. Ann. Rheumatic Diseases. 1957;16(4):494-502.
  7. Peterfy C.G. Whole-Organ Magnetic Resonance Imaging Score (WORMS) of the knee in osteoarthritis. Osteoarthritis and Cartilage. 2004;12(3):177-90.
  8. Светлова М.С. Патогенетическое лечение остеоартроза коленных суставов. Современная ревматология. 2012;3:45-8.
  9. Raynauld J.P., Pelletier J.P., Abram F., Dodin P., Delorme P., Martel-Pelletier J. Long-Term Effects of Glucosamine and Chondroitin Sulfate on the Progression of Structural Changes in Knee Osteoarthritis: Six-Year Followup Data From the Osteoarthritis Initiative. Arthritis Care Res (Hoboken). 2016;68(10):1560-66.
  10. Fransen M., Agaliotis M., Nairn L., Votrubec M., Bridgett L., Su S., Jan S., March L., Edmonds J., Norton R., Woodward M., Day R. Glucosamine and chondroitin for knee placebo-controlled clinical trial evaluating osteoarthritis: a doubleblind randomised single and combination regimens. Ann. Rheum. Dis. 2014;0:1-8.
  11. Hochbergy M.C., et al. The Multicentric Osteoarthritis intervention Study with Sysadoa (MOVES). MOVES Steering Committee. Osteoarthritis and Cartilage. 2014;22:7-56.
  12. Wang C.T. Therapeutic effects of hyaluronic acid on osteoarthritis of the knee. A metaanalysis of randomized controlled trials. J. Bone and Joint Surgery. American Volume. 2004; 86(3):538-45.
  13. Frizziero L., Govoni E., Bacchini P. Intra-articular hyaluronic acid in the treatment of osteoarthritis of the knee: clinical and morphological study. Clinical and Experimental Rheumatology. 1998;16(4):441-49.
  14. Listrat V. Arthroscopic evaluation of potential structure modifying activity of hyaluronan (Hyalgan) in osteoarthritis of the knee. Osteoarthritis and Cartilage. 1997; 5(3):153-60.

Supplementary files

Supplementary Files
Action
1. JATS XML

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies